Boc-Leu-Gly-OH

Boc-Leu-Gly-OH is a protected dipeptide building block combining leucine and glycine in a Boc-protected, peptide-coupling-ready format. The Boc group provides an N-terminal protection strategy commonly used in stepwise peptide assembly, while the free carboxylic acid enables incorporation into longer peptide sequences through standard coupling chemistry. This reagent is frequently selected for controlled segment condensation and for preparing defined peptide intermediates where maintaining the N-terminus is essential during iterative synthesis.

1. Segment Condensation Intermediate

Boc-Leu-Gly-OH is used as a dipeptide segment for constructing longer peptides via solution-phase or automated stepwise assembly workflows. Researchers in custom peptide manufacturing and peptide process development rely on such protected dipeptide units to introduce the Leu-Gly motif with minimal sequence ambiguity, improving reproducibility across scale-up batches. The presence of a Boc-protected N-terminus supports compatibility with protected-peptide fragment strategies, allowing downstream coupling to extend the chain while keeping the terminal amino functionality protected until the intended stage.

2. Solid-Phase Peptide Assembly

Boc-Leu-Gly-OH is commonly applied when a protected dipeptide fragment is needed to seed or extend sequences during solid-phase peptide synthesis, particularly in workflows that benefit from pre-assembled short segments. Peptide synthesis groups use this type of building block to reduce the number of coupling steps required to reach a target sequence region, which can help streamline synthesis planning for defined constructs. The free C-terminal carboxylic acid on the fragment provides a direct handle for attachment to the growing peptide, while the Boc protection supports controlled handling of the N-terminus during iterative assembly.

3. Defined Peptide Standards

Boc-Leu-Gly-OH is also used in analytical and method-development contexts where defined peptide fragments are required as reference materials. Analytical chemistry teams preparing LC-MS workflows, peptide mapping experiments, or calibration/qualification sets may use protected dipeptide building blocks to generate consistent standards that reflect specific sequence elements. Because the reagent contains a defined Leu-Gly composition and a protected N-terminus, it supports reproducible sample preparation when monitoring fragment formation, verifying synthetic intermediates, or benchmarking peptide coupling performance in development pipelines.

4. Pharmaceutical Intermediate Development

Boc-Leu-Gly-OH serves as a practical intermediate for medicinal chemistry programs that require sequence-precise peptide-like fragments or peptidomimetic precursors. Chemical development groups use protected dipeptide units to assemble larger, well-defined intermediates that can be further functionalized or incorporated into candidate molecules. In this role, the reagent's protected N-terminus and carboxylic acid functionality support downstream transformations consistent with intermediate manufacturing workflows, enabling controlled progression from small, defined building blocks toward larger synthetic targets.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics